| ACUIX | DODGX | ACUIX / DODGX | |
| Total Expense Ratio | 1.78 | 0.51 | 349% |
| Annual Report Gross Expense Ratio | 1.78 | 0.51 | 349% |
| Fund Existence | 26 years | 62 years | - |
| Gain YTD | 19.115 | 11.251 | 170% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 2500 | 80% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.63B | 123B | 2% |
| Annual Yield % from dividends | 1.55 | 1.05 | 148% |
| Returns for 1 year | 19.98 | 14.66 | 136% |
| Returns for 3 years | 43.25 | 116.11 | 37% |
| Returns for 5 years | 28.65 | 162.69 | 18% |
| Returns for 10 years | 44.52 | 487.09 | 9% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MSFU | 37.72 | 0.64 | +1.73% |
| Direxion Daily MSFT Bull 2X Shares | |||
| WAMA | 27.30 | 0.19 | +0.71% |
| WisdomTree U.S. Adaptive Moving Average | |||
| FLOT | 50.95 | 0.02 | +0.04% |
| iShares Floating Rate Bond ETF | |||
| QMAG | 25.67 | N/A | +0.02% |
| FT Vest Nasdaq-100 Mod Buffr ETF - Aug | |||
| IBRN | 39.57 | N/A | N/A |
| iShares Neuroscience and Healthcare ETF | |||